NAD+ 1000mg

NAD+ 1000 mg is a high-purity lyophilized research compound supplied exclusively for scientific investigation and controlled laboratory experimentation.

For research use only — not for human or veterinary use.

 

Product Overview

NAD+ (Nicotinamide Adenine Dinucleotide) is a research compound widely investigated in controlled laboratory studies involving cellular biochemistry, molecular signalling, redox systems and metabolic regulatory pathways.

Its defined molecular structure and central role within biochemical research have made NAD+ an important experimental material for investigations involving intracellular molecular processes, cellular energy pathways and oxidation-reduction systems under carefully controlled laboratory conditions.

This preparation contains 1000 mg of lyophilized NAD+ supplied in a sealed research vial. Independent analytical testing confirmed an assay content of 996 mg for this production batch.

Chromatographic analysis confirmed 98.0 percent purity, while identity was independently evaluated through FTIR spectrum analysis, retention time confirmation and molecular ion mass identification.

Microbiological testing reported 0 CFU/g for both total aerobic microbial count and total yeast and mold count, while bacterial endotoxin analysis returned a result of 0.003 EU/mg.

Comprehensive elemental impurity screening additionally reported arsenic, cadmium, mercury, lead, nickel, vanadium and cobalt below 0.001 ppm.

With its independently verified assay content, defined molecular identity and comprehensive third-party analytical documentation, NAD+ provides researchers with a well-characterised research material suitable for advanced biochemical investigations and controlled in vitro laboratory studies.

 

Compound Overview

NAD+ is a naturally occurring dinucleotide research compound extensively investigated within cellular biochemistry, molecular biology and metabolic research.

Researchers employ NAD+ in controlled experimental models involving intracellular biochemical processes, oxidation-reduction systems, molecular interactions and cellular regulatory pathways.

Its defined molecular characteristics allow identity and analytical quality parameters to be evaluated using complementary chromatographic, spectroscopic and mass spectrometric techniques.

NAD+ is particularly relevant within experimental models designed to investigate cellular redox chemistry, biochemical energy-transfer systems and intracellular molecular communication under carefully controlled laboratory conditions.

Today, NAD+ continues to be extensively investigated throughout biochemical, molecular and cellular research.

 

Historical Background and Scientific Context

NAD+ has long been an important subject within biochemical research because of its involvement in fundamental cellular oxidation-reduction reactions and molecular metabolic processes.

Advances in analytical chemistry have significantly improved the ability to independently characterise NAD+ research materials and evaluate batch-specific analytical quality.

Modern analytical technologies including chromatographic assay determination, purity analysis, FTIR spectrum identification, retention time comparison and mass spectrometry provide complementary information regarding compound identity and analytical characteristics.

These techniques can be combined with bacterial endotoxin testing, microbiological analysis and elemental impurity screening to provide comprehensive batch-specific analytical documentation.

NAD+ remains an important research compound utilised in controlled investigations involving cellular biochemistry, redox biology, metabolic signalling and molecular regulatory systems.

 

Mechanistic Focus in Research

Within controlled laboratory environments, NAD+ is commonly investigated in relation to cellular biochemistry, redox systems and intracellular molecular pathways.

Research investigations frequently explore:

• Cellular redox biology
• Oxidation-reduction systems
• Intracellular biochemical pathways
• Cellular energy metabolism research
• Molecular signalling mechanisms
• Metabolic regulatory pathways
• Biochemical pathway analysis
• Controlled in vitro laboratory studies

These experimental models allow researchers to investigate NAD+-associated biochemical processes while maintaining carefully controlled laboratory conditions.

 

Analytical Verification (COA)

Each batch of NAD+ supplied by Grail Formula undergoes comprehensive independent third-party laboratory verification to confirm identity, assay content, purity and microbiological quality.

Analytical testing for this batch was performed by Liquilabs s.r.o. Czechia using chromatographic, spectrometric, microbiological and mass spectrometry techniques.

Batch: GF-NAD10-B243

• Assay Content: 996 mg
• Purity: 98.0 %
• Identification by FTIR Spectrum: 995
• Identification by Retention Time: 0.997
• Molecular Ion Mass Identification: 663 Da
• Bacterial Endotoxins: 0.003 EU/mg
• Total Aerobic Microbial Count: 0 CFU/g
• Total Yeast and Mold Count: 0 CFU/g

Independent polar compound screening measured an assay content of 996 mg with a reported analytical uncertainty of ±5 mg.

Purity analysis confirmed 98.0 percent purity with a reported analytical uncertainty of ±0.5 percent.

Identity was evaluated through FTIR spectrum analysis with a reported result of 995 and retention time analysis with a result of 0.997.

Mass spectrometry identified a molecular ion mass of 663 Da with a reported analytical uncertainty of ±1 Da, providing an additional independent identity parameter for the tested material.

Bacterial endotoxin testing returned a result of 0.003 EU/mg, within the laboratory’s reported acceptable range of 0–0.5 EU/mg.

Microbiological testing reported 0 CFU/g for total aerobic microbial count and 0 CFU/g for total yeast and mold count, within the laboratory’s reported acceptable ranges of 0–1000 CFU/g and 0–100 CFU/g respectively.

Independent elemental impurity analysis reported arsenic, cadmium, mercury, lead, nickel, vanadium and cobalt below 0.001 ppm, with all reported results within the laboratory’s stated acceptable ranges.

These analytical procedures provide independent confirmation of NAD+ identity, assay content, purity, traceability and important batch-specific laboratory quality parameters.

 

Research Applications

Within controlled laboratory environments, NAD+ may be utilised in experimental models designed to investigate cellular biochemistry, redox systems, intracellular signalling pathways and molecular regulatory mechanisms.

Examples of research applications include:

• Cellular redox investigations
• Oxidation-reduction pathway research
• Cellular energy metabolism research
• Intracellular biochemical studies
• Molecular signalling investigations
• Metabolic pathway analysis
• Comparative biochemical investigations
• Controlled in vitro laboratory studies

These applications are intended exclusively for scientific and laboratory investigation.

 

Grail Formula Quality

Every Grail Formula research compound is supported by comprehensive independent analytical verification and transparent batch-specific laboratory documentation.

Each production batch undergoes extensive testing to verify:

• Compound identity confirmation
• Assay content verification
• Purity assessment
• Molecular ion mass verification
• Retention time confirmation
• FTIR spectrum identification
• Endotoxin analysis
• Microbial contamination screening
• Elemental impurity screening
• Complete batch traceability

Independent laboratory testing helps provide researchers with reliable, reproducible and transparently documented research material suitable for advanced scientific investigation.

 

When You Choose Grail Formula

When selecting Grail Formula, researchers receive independently verified research compounds supported by complete Certificates of Analysis and transparent batch-specific laboratory documentation.

For NAD+ 1000 mg batch GF-NAD10-B243, independent analysis was performed by Liquilabs s.r.o. Czechia and the Certificate of Analysis was published on 10 September 2026.

Our analytical verification programme includes assay determination, purity confirmation, FTIR spectrum identification, retention time verification, molecular ion mass identification, endotoxin screening, microbiological analysis and comprehensive elemental impurity testing.

Every production batch is accompanied by a downloadable Certificate of Analysis issued by Liquilabs s.r.o. Czechia, providing complete traceability, independent verification and confidence in the analytical quality of every research compound supplied.

 

Research Use Limitation

• Used solely for laboratory and in vitro research
• Not approved for human consumption
• Not approved for veterinary use
• Not intended for diagnostic purposes
• Not intended for therapeutic applications
• Not permitted for clinical administration
• For research use only

• Independently analysed by Liquilabs s.r.o. Czechia
• 98.0 % purity confirmed by COA
• Assay content verified at 996 mg
• Identification confirmed by FTIR spectrum and retention time analysis
• Molecular ion mass identified at 663 Da
• Bacterial endotoxin level of 0.003 EU/mg
• Total aerobic microbial count: 0 CFU/g
• Total yeast and mold count: 0 CFU/g
• All reported elemental impurities below 0.001 ppm
• Complete batch-specific COA traceability
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.